These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30391801)

  • 1. Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming.
    Zhu L; Kalimuthu S; Oh JM; Gangadaran P; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Biomaterials; 2019 Jan; 190-191():38-50. PubMed ID: 30391801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
    Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Front Immunol; 2018; 9():824. PubMed ID: 29740437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
    Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel alternatives to extracellular vesicle-based immunotherapy - exosome mimetics derived from natural killer cells.
    Zhu L; Gangadaran P; Kalimuthu S; Oh JM; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S166-S179. PubMed ID: 30092165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18.
    Aarsund M; Segers FM; Wu Y; Inngjerdingen M
    Cancer Immunol Immunother; 2022 Sep; 71(9):2227-2238. PubMed ID: 35119498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome Analysis of Human Natural Killer Cell Derived Extracellular Vesicles for Identification of Anticancer Effectors.
    Choi JW; Lim S; Kang JH; Hwang SH; Hwang KC; Kim SW; Lee S
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33182448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities.
    Hu W; Wang G; Huang D; Sui M; Xu Y
    Front Immunol; 2019; 10():1205. PubMed ID: 31214177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of circulating extracellular vesicles with altered expression and function during pregnancy.
    Nardi Fda S; Michelon TF; Neumann J; Manvailer LF; Wagner B; Horn PA; Bicalho Mda G; Rebmann V
    Immunobiology; 2016 Jul; 221(7):753-60. PubMed ID: 27005781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy.
    Wu F; Xie M; Hun M; She Z; Li C; Luo S; Chen X; Wan W; Wen C; Tian J
    Front Immunol; 2021; 12():658698. PubMed ID: 34093547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
    BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.
    Jiang W; Zhang C; Tian Z; Zhang J
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1279-1288. PubMed ID: 29737430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins.
    Aarsund M; Nyman TA; Stensland ME; Wu Y; Inngjerdingen M
    Front Immunol; 2022; 13():977353. PubMed ID: 36189227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?
    Fabbri M
    Cancer Res; 2020 Jan; 80(1):17-22. PubMed ID: 31672842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles from
    Luo ZW; Xia K; Liu YW; Liu JH; Rao SS; Hu XK; Chen CY; Xu R; Wang ZX; Xie H
    Int J Nanomedicine; 2021; 16():2949-2963. PubMed ID: 33907401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-Time Tracking of
    Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
    Front Immunol; 2018; 9():825. PubMed ID: 29770131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-enhanced cytolytic activity of exosomes from NK Cells.
    Enomoto Y; Li P; Jenkins LM; Anastasakis D; Lyons GC; Hafner M; Leonard WJ
    Cancer Gene Ther; 2022 Jun; 29(6):734-749. PubMed ID: 34316033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T-cells and tumour cells.
    Del Vecchio F; Martinez-Rodriguez V; Schukking M; Cocks A; Broseghini E; Fabbri M
    J Extracell Vesicles; 2021 Apr; 10(6):e12075. PubMed ID: 33815694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
    Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell-derived extracellular vesicles in cancer therapy.
    Farcas M; Inngjerdingen M
    Scand J Immunol; 2020 Oct; 92(4):e12938. PubMed ID: 32697853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.